SCHEDULE 13D/A

LANTERN PHARMA INC

Common Stock, par value $0.0001 per share · CUSIP: 51654W101

Event date: 2026-02-20

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Bios Fund I, LPReported CIK 0001697316

  Shares: 287,619 · Class: 2.57%

• BIOS EQUITY PARTNERS II, LPReported CIK 0001813313

  Shares: 478,079 · Class: 4.27%

• BIOS FUND I QP, LPReported CIK 0001700297

  Shares: 168,235 · Class: 1.5%

• BIOS FUND II, LPReported CIK 0001714576

  Shares: 101,665 · Class: 0.91%

• BIOS FUND II QP, LPReported CIK 0001716869

  Shares: 331,974 · Class: 2.97%

• BIOS FUND II NT, LPReported CIK 0001728851

  Shares: 44,440 · Class: 0.4%

• BP DIRECTORS, LPReported CIK 0001813311

  Shares: 26,093 · Class: 0.23%

• BIOS EQUITY PARTNERS, LPReported CIK 0001813314

  Shares: 481,947 · Class: 4.31%

• BIOS CAPITAL MANAGEMENT, LPReported CIK 0001813845

  Shares: 960,026 · Class: 8.58%

• BIOS ADVISORS GP, LLCReported CIK 0001813844

  Shares: 960,026 · Class: 8.58%

• CAVU MANAGEMENT, LPReported CIK 0001813270

  Shares: 960,026 · Class: 8.58%

• CAVU ADVISORS, LLCReported CIK 0001813310

  Shares: 960,026 · Class: 8.58%

• LESLIE W. KREISReported CIK 0001813316

  Shares: 960,026 · Class: 8.58%

• AARON G.L. FLETCHERReported CIK 0001789490

  Shares: 960,026 · Class: 8.58%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.